TY - JOUR
T1 - Cooperative cardiovascular project (CCP) quality improvement in Maine, New Hampshire, and Vermont
AU - Ramunno, Lawrence D.
AU - Dodds, T. Andrew
AU - Traven, Neal D.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1998
Y1 - 1998
N2 - The Cooperative Cardiovascular Project (CCP) is a nationwide quality improvement project (quality indicator measurement, feed-back, remeasurement) in Medicare acute myocardial infarction (AMI) patients sponsored by the Health Care Financing Administration (HCFA). In Maine, New Hampshire, and Vermont, 3,472 baseline records were abstracted from 76 hospitals from January 1994 to February 1995. After feedback, 2,270 remeasurements were collected from October 1996 to May 1997. At remeasurement, performance improved significantly for 'ideal' candidates (defined by the CCP) on five quality indicators - aspirin during hospitalization 88% to 93% (p < .001), thrombolytic timing 60% to 69% (p < .01), discharge aspirin 83% to 90% (p < .001), discharge beta-blockers 69% to 82% (p < .01), and calcium channel blocker avoidance 83% to 93% (p < .05). Reperfusion, angiotensin converting enzyme inhibitors, and smoking cessation advice did not improve significantly. This study demonstrates that evidence-based indicators, nationally designed data collection, and locally based interventions can significantly improve AMI care.
AB - The Cooperative Cardiovascular Project (CCP) is a nationwide quality improvement project (quality indicator measurement, feed-back, remeasurement) in Medicare acute myocardial infarction (AMI) patients sponsored by the Health Care Financing Administration (HCFA). In Maine, New Hampshire, and Vermont, 3,472 baseline records were abstracted from 76 hospitals from January 1994 to February 1995. After feedback, 2,270 remeasurements were collected from October 1996 to May 1997. At remeasurement, performance improved significantly for 'ideal' candidates (defined by the CCP) on five quality indicators - aspirin during hospitalization 88% to 93% (p < .001), thrombolytic timing 60% to 69% (p < .01), discharge aspirin 83% to 90% (p < .001), discharge beta-blockers 69% to 82% (p < .01), and calcium channel blocker avoidance 83% to 93% (p < .05). Reperfusion, angiotensin converting enzyme inhibitors, and smoking cessation advice did not improve significantly. This study demonstrates that evidence-based indicators, nationally designed data collection, and locally based interventions can significantly improve AMI care.
UR - http://www.scopus.com/inward/record.url?scp=0031756911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031756911&partnerID=8YFLogxK
U2 - 10.1177/016327879802100404
DO - 10.1177/016327879802100404
M3 - Review article
C2 - 10351558
AN - SCOPUS:0031756911
SN - 0163-2787
VL - 21
SP - 442
EP - 460
JO - Evaluation and the Health Professions
JF - Evaluation and the Health Professions
IS - 4
ER -